Ebi3tm1.1Daav
Targeted Allele Detail
|
|
| Symbol: |
Ebi3tm1.1Daav |
| Name: |
Epstein-Barr virus induced gene 3; targeted mutation 1.1, Dario Vignali |
| MGI ID: |
MGI:6739821 |
| Synonyms: |
Ebi3L, Ebi3Tom.L |
| Gene: |
Ebi3 Location: Chr17:56259640-56264022 bp, + strand Genetic Position: Chr17, 29.08 cM
|
| Alliance: |
Ebi3tm1.1Daav page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:254697
|
| Parent Cell Line: |
JM8.N4 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change, Reporter) |
| Mutations: |
|
Insertion, Intragenic deletion
|
| |
|
Mutation details: The targeting construct replaced the translation initiation sequence with a tdTomato and 2A sequence and inserted a loxP site into intron 1 and an FRT-flanked neomycin resistance cassette, loxP site, and Thy1.1 cDNA into intron 5. Flp-mediated mutation removed the selection cassette.
(J:254697)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Ebi3 Mutation: |
13 strains or lines available
|
|
| Original: |
J:254697 Turnis ME, et al., Interleukin-35 Limits Anti-Tumor Immunity. Immunity. 2016 Feb 16;44(2):316-29 |
| All: |
7 reference(s) |
|